1024 GMT - Novo Nordisk will further scale up its production, supply and employment to drive innovation, its executive vice president for Commercial Strategy & Corporate Affairs, Camilla Sylvest, tells Bloomberg TV at the World Economic Forum in Davos, Switzerland. Innovation is key to compete with other players, Sylvest says when asked about industry peers grappling with patent losses by the end of the decade. "It's a big task, that's why you see us continue to scale both in production, product supply, bringing those treatment to patients, but also in terms of the number of people we employ in our company," Sylvest says. (helena.smolak@wsj.com)
(END) Dow Jones Newswires
January 22, 2025 05:24 ET (10:24 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。